glp 1 gip gcg GLP-1R, GIPR, and GCGR: Targets for Obesity and Diabetes The Road towards Triple Agonists:

Metformin has also been found to result in modest but clinically significant weight loss

This means it is engineered to activate two different, naturally occurring hormone receptors in the body that are crucial for regulating metabolism and appetite

The importance of the fatty acid transporter L-Carnitine in Non-Alcoholic fatty liver disease (NAFLD)

As a result, Medicaid coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for other indications (diabetes, cardiovascular disease, and sleep apnea)

These are super common questions when thinking about stepping away from your medication